ARCHIVES

DCT To Announce Three New CRAGs

This article is from The Cancer Letter archive.

Vol. 02 No. 46 | November 12, 1976

Download PDF Visit The Full Archive

Related Articles

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

November 28, 2014

FDA Approves New Drug for Advanced Kidney Cancer

May 25, 2007

INSPIRE Enrollment Stopped; Thromboembolism Risk Cited

February 25, 2011

US Appeals Court Dismisses Fisher’s Privacy Act Suit Supporting Femara

January 10, 1997

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

September 18, 1987

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006